Jim Nasr

Jim Nasr is an accomplished technology executive and software architect with a focus on creating cutting-edge solutions for the healthcare industry. He holds an MBA in Management from the University of Connecticut School of Business, a Master of Business Administration with a specialization in Information Technology from the University of Connecticut, and a BSc in Computer Science and Statistics from Coventry University.

Throughout his career, Jim Nasr has held key roles in various prestigious organizations, showcasing his expertise and leadership. Some of his notable positions include serving as the Chief Executive Officer at Acoer, Vice President of Technology & Innovation at Synchrogenix (a Certara company), and Chief Software Architect at the Centers for Disease Control and Prevention.

Jim Nasr has also been actively involved in industry associations and standards development. He has served as the Chair of the Interoperable Data Security Subcommittee for Decentralized Clinical Trials at IEEE, as well as the Co-Chair of the Supply Chain/Clinical Trials Technology Implementation Industry Connections at IEEE. Furthermore, he has contributed to the advancement of healthcare technology through roles such as the Privacy & Healthcare Fund Lead at The HBAR Foundation and as an External Expert Advisory Board Member at PharmaLedger.

Additionally, Jim Nasr has a strong background in software development and open-source projects. He has been a Board Member at Armedia, a Committer and PMC member of Apache Chemistry at The Apache Software Foundation, and the Co-Founder and CEO of Armedia. With experience at well-known tech companies like Sapient and IBM, Jim Nasr brings a wealth of expertise in software architecture and development.

Furthermore, Jim Nasr's contributions extend to academia, with a focus on advancing technology and innovation in healthcare. His diverse experience, spanning from leading roles in various organizations to active participation in industry standards committees, showcases his dedication to driving progress and innovation in the healthcare technology sector.